GlassScriptPhysician profile
Juanito U Uy
NPI 1851531149
$31,632.75
in general payments reported to CMS, 2019-2025
45 companies · $1,110 in 2025
The $1,110 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $5,145 · 2021: $6,556 · 2022: $2,112 · 2023: $1,516 · 2024: $2,216 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,831 · Education: $12.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,830.75 |
| Education | $12.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14,735.99 | 2019-2024 | Farxiga, Airsupra, Breztri |
| Merck Sharp & Dohme LLC | $6,688.99 | 2019-2024 | Verquvo, Belsomra, Steglatro |
| Lilly USA, LLC | $1,720.62 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $1,224.30 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $1,047.34 | 2019-2024 | Freestyle Libre 3 |
| Amgen INC. | $696.12 | 2019-2025 | Evenity, Tepezza, Repatha |
| Insulet Corporation | $667.13 | 2019-2024 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $533.91 | 2019-2024 | Jardiance |
| Xeris Pharmaceuticals, INC. | $462.03 | 2021-2024 | Gvoke Hypopen, Recorlev |
| Bayer Healthcare Pharmaceuticals INC. | $408.84 | 2021-2024 | |
| Abbvie INC. | $408.50 | 2020-2024 | Linzess, Viberzi, Ubrelvy |
| Esperion Therapeutics, INC. | $402.37 | 2021-2024 | Nexletol |
| Dexcom, INC. | $377.28 | 2019-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $239.73 | 2019-2023 | Xarelto |
| Amneal Pharmaceuticals LLC | $188.14 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juanito Uy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.